MabAll Rituximab 500mg Vail

MabAll Rituximab 500mg Vial is a powerful medication designed to target specific cells in the body involved in the immune response. Each vial contains 500mg of rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, which are often implicated in certain types of cancers and autoimmune diseases.

Mode of Action: Rituximab, the active ingredient in MabAll Rituximab 500mg Vial, works by binding to CD20 antigen present on the surface of B-cells. This binding triggers various immune mechanisms, including antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, leading to the destruction of targeted B-cells. By depleting these abnormal B-cells, rituximab helps modulate the immune response and combat diseases.

Indications: MabAll Rituximab 500mg Vial is indicated for the treatment of:

• Non-Hodgkin's Lymphoma
• Chronic Lymphocytic Leukemia
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
• Microscopic Polyangiitis

Dosage and Administration: The recommended dosage of MabAll Rituximab 500mg Vial varies depending on the specific condition being treated, the patient's weight, and other factors. It is typically administered intravenously by a healthcare professional over a specified period. Dosage and administration should be tailored to the individual patient's needs and medical history.

Precautions:

• Prior to initiating treatment with MabAll Rituximab 500mg Vial, patients should undergo thorough medical evaluation, including screening for hepatitis B virus (HBV) infection.
• Close monitoring for signs of infusion reactions, infections, and other adverse effects is essential during and after rituximab therapy.
• Patients should receive appropriate premedication to reduce the risk of infusion-related reactions.
• Rituximab should be used with caution in patients with a history of cardiac or pulmonary conditions.

Side Effects: Common side effects associated with MabAll Rituximab 500mg Vial may include:

• Infusion reactions (fever, chills, nausea, headache, rash)
• Fatigue
• Infections (upper respiratory tract infections, urinary tract infections)
• Low white blood cell count (neutropenia)
• Low platelet count (thrombocytopenia)
• Hypertension (high blood pressure)